Report of an atypical case with arrhythmogenic right ventricular dysplasia or Uhl´s anomaly
Keywords:
arrhythmogenic right ventricular dysplasia, cardiomyopathyAbstract
Arrhythmogenic right ventricular dysplasia is a cardiomyopathy characterized by malignant ventricular arrhythmias and progressive structural abnormalities, affecting primarily the right ventricle. It appears due to a partial or massive progressive replacement of the myocardium by fibroadipose or adipose tissue. Uhl's disease may be an extreme and widespread manifestation of arrhythmogenic right ventricular dysplasia, a rare congenital disorder with absence of right ventricular myocardium, so that its walls are paper thin. The case of a 56 year old male patient who had loss of consciousness and underwent clinical and echocardiographic diagnosis is presented. The clinical features, diagnosis and action to take against this potentially fatal heart disease in patients with syncope, ventricular tachycardia or cardiac arrest are discussed.
Downloads
References
Frank R, Fontaine G, Mialet G, Sol C, Guiraudon G, Grosgogeat Y. Electrocardiologie de cas de dysplasie ventriculaire droite arythmogene. Arch Mal Coeur Vaiss. 1978;71(9):963-72.
Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomiopathy and sudden death in young people. N Engl J Med. 1988;318(3):129-33.
Fontaine GH, Guiraudon G, Frank R. Stimulation studies and epicardial mapping in ventricular tachycardia: study of mechanisms and selection for surgery. In: Kulbertus He, ed. Re-entrant arrhythmias: mechanisms and treatment. Baltimore: University Park Press; 1977. p. 334-50.
Anderson EL. Arrhythmogenic right ventricular dysplasia. Am Fam Physician. 2006;73(8):1391-8.
Gallo P, D´Amati G, Pelliccia F. Pathologic evidence of extensive left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy. Hum Pathol. 1992;23(8):948-52.
Thiene G, Basso C. Arrhythmogenic right ventricular cardiomyopathy: an update. CardiovascPathol. 2001;10(3):109-17.
Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation. 1982;65(2):384-98.
Thiene G, Corrado D, Basso C. Arrhythmogenic right ventricular cardiomiopathy/dysplasia. Orphanet J Rare Dis. 2007;2:45.
Kayser H, Van der Wall EE, PleinS,Bloomer TN, de Roos A. Diagnosis of arrhythmogenic right ventricular dysplasia: a review. Radiographics. 2002; 22(3):639-48.
Morales Pérez LM, Jerez Castro AM, San Román García E. Displasia arritmogénica del ventrículo derecho o enfermedad de UHL. RevFedArgCardiol. 2012;41(1):59-60.
Gaffney FA, Nicod P, Lin JC, Rude RE. Noninvasive recognition of the parchment right ventricle (Uhl´s anomaly arrhythmogenic right ventricular dysplasia) syndrome. ClinCardiol. 1983;6(5):235-42.
Daliento L, Rizzoli G, Thiene G, Nava A, Rinuncini M, Chioin R, et al. Diagnostic accuracy of right ventriculography in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol. 1990;66(7):741-5.
Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J. 2010;31(7):806-14.
Rampazzo A, Nava A, Malacrida S, Beffagna G, Bauce B, Rossi V, et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J HumGenet. 2002;71(5):1200-6.
Gerull B, Heuser A, Wichter T, Paul M, Basson CT, McDermott DA, et al. Mutations in the desmosomal protein plakophilin 2 are common in arrhythmogenic right ventricular cardiomiopathy. Nat Genet. 2004;36(11):1162-4.
Capulzini L, Brugada P, Brugada J, Brugada R. Arritmias y enfermedades del corazón derecho: de las bases genéticas a la clínica.Rev EspCardiol. 2010;63(8):964-5.
Corrado D, Basso C, Thiene G, McKenna WJ, Davies MJ, Fontaliran F, et al. Spectrum of clinicophatologic manifestations of arrhythmogenic right ventricular cardiomiopathy/dysplasia: a multicenter study. J A CollCardiol. 1997;30(6):1521-30.
McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom−Lundqvist C, Fontaine G, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J. 1994;71(3):215-8.
Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke D, et al. Diagnosis of arrythmogenic right ventricular cardiomyopathy/dysplasia. Proposed modification of the Task Force criteria. Circulation. 2010;121(13):1533-41.
Daliento L, Rizzoli G, Thiene G, Nava A, Rinuncini M, Chioin R, et al. Diagnostic accuracy of right ventriculography in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol. 1990;66:741-5.
Van der Wall EE, Kayser HW, Bootsma MM, De RoosA, Schalij MJ. Arrhythmogenic right ventricular dysplasia: MRI findings. Herz. 2000;25(4):356-64.
Tandri H, Bomma C, Calkins H, Bluemke DA. Magnetic resonance and computed tomography imaging of arrhythmogenic right ventricular dysplasia. J MagnReson Imaging. 2004;19(6):848-58.
Burke AP, Farb A, Tashko G, Virmani R. Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases? Circulation. 1998;97(16):1571-80.
Hulot JS, Jouven X, Empana JP, Frank R, Fontaine G. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomiopathy. Circulation. 2004;110:1879-84.
Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease: results in patients with inducible and noninducible ventricular tachycardia. Circulation. 1992;86(1):29-37.
Marcus G, Glidden D, Polonsky B, Zareba W, Smith L, Cannom D, et al. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomiopathy. J Am CollCardiol. 2009;54(7):609-15.
Arruda M, Armaganijan TF, Di Biase L, Patel D, Natale A. Catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplsia. J IntervCardElectrophysiol. 2009;25(2):129-33.
Wichter T, Brethardt G. Implantable cardioverter−defibrillator therapy in arrhythmogenic right ventricular cardiomiopathy: a role for genotyping in decision−making? J Am CollCardiol. 2005;45(3):409-11.
Hodgkinson KA, Parfrey PS, Bassett AS, Kupprion C, Drenckhahn J, Norman MW, et al. The impact of implantable cardioverter defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomiopathy (ARVD5). J Am CollCardiol. 2005;45(3):400-8.
Turrini P, Basso C, Daliento L, Nava A, Thiene G, et al. Is arrhythmogenic right ventricular cardiomyopathy a pediatric problem too? Images PaediatrCardiol. 2000;3(1):18-37.
Downloads
Published
How to Cite
License
Copyright (c) 2012 CorSalud
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
